(Q44698995)

5 December 2017

title

Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects (English)

1 reference

5 December 2017

A López-Quílez

3

0 references

author name string

C Armero

series ordinal

1

1 reference

5 December 2017

G García-Donato

series ordinal

2

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

5 December 2017

1 reference

5 December 2017

volume

19

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

629-643

1 reference

Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease

5 December 2017

cites work

1 reference

Bayesian assessment of sample size for clinical trials of cost-effectiveness

21 January 2018

1 reference

Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

21 January 2018

1 reference

7 January 2021

Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial

1 reference

7 January 2021

The case for objective Bayesian analysis

1 reference

7 January 2021

Choice of hierarchical priors: admissibility in estimation of normal means

1 reference

7 January 2021

Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis

1 reference

7 January 2021

Handling uncertainty in cost-effectiveness models

1 reference

7 January 2021

An introduction to Markov modelling for economic evaluation

1 reference

7 January 2021

A Bayesian approach to analysing the cost-effectiveness of two primary care interventions aimed at improving attendance for breast screening.

1 reference

7 January 2021

A Bayesian approach to modelling the natural history of a chronic condition from observations with intervention.

1 reference

7 January 2021

Primer on Medical Decision Analysis: Part 2—Building a Tree

1 reference

7 January 2021

Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis

1 reference

7 January 2021

Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine

1 reference

7 January 2021

Adaptive Rejection Metropolis Sampling within Gibbs Sampling

1 reference

7 January 2021

Economic evaluation of long-term management strategies for erosive oesophagitis

1 reference

7 January 2021

Bayesian Survival Analysis

1 reference

7 January 2021

The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis.

1 reference

7 January 2021

The Selection of Prior Distributions by Formal Rules

1 reference

7 January 2021

How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.

1 reference

7 January 2021

Healing of grade-II and III oesophagitis through motility stimulation with cisapride

1 reference

7 January 2021

The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis

1 reference

7 January 2021

Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane

1 reference

7 January 2021

Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

1 reference

7 January 2021

Bayesian cost-effectiveness analysis from clinical trial data

1 reference

7 January 2021

Cisapride in the treatment of gastro-oesophageal reflux disease

1 reference

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

7 January 2021

Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling

1 reference

7 January 2021

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

7 January 2021

Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEC.1496

1 reference

5 December 2017

1 reference